Haoyu Fu

Chinese Academy Of Sciences 555 Zuchongzhi Road
Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

From Rational Design to Bioactivity Enhancement: Novel Benzofuranone Insecticide Discovery Assisted by a Calix[4]arene-Based Supramolecular Strategy.

From Rational Design to Bioactivity Enhancement: Novel Benzofuranone Insecticide Discovery Assisted by a Calix[4]arene-Based Supramolecular Strategy.

Journal: Journal of agricultural and food chemistry

Published: June 02, 2026

From Molecular Recognition to Behavioral Control: Dual-Target Aphid Repellent Discovery of Novel Ionone Derivatives.

From Molecular Recognition to Behavioral Control: Dual-Target Aphid Repellent Discovery of Novel Ionone Derivatives.

Journal: Journal of agricultural and food chemistry

Published: May 28, 2026

Discovery of multi-chitinase inhibitors cinnamyl thiazolidinone compounds as candidates for insect growth regulators via ligand-based optimization strategies.

Discovery of multi-chitinase inhibitors cinnamyl thiazolidinone compounds as candidates for insect growth regulators via ligand-based optimization strategies.

Journal: International journal of biological macromolecules

Published: October 13, 2024

Regulation of three novel pepper thiothiazolidinones on the fecundity of Spodoptera frugiperda.

Regulation of three novel pepper thiothiazolidinones on the fecundity of Spodoptera frugiperda.

Journal: Pesticide biochemistry and physiology

Published: May 26, 2024

Five New Species of the Genus Hymenogaster (Hymenogastraceae, Agaricales) from Northern China.

Five New Species of the Genus Hymenogaster (Hymenogastraceae, Agaricales) from Northern China.

Journal: Journal of fungi (Basel, Switzerland)

Published: March 01, 2024

Combined inhibition of PARP and ATR synergistically potentiates the antitumor activity of HER2-targeting antibody-drug conjugate in HER2-positive cancers.

Combined inhibition of PARP and ATR synergistically potentiates the antitumor activity of HER2-targeting antibody-drug conjugate in HER2-positive cancers.

Journal: American journal of cancer research

Published: October 30, 2022

Trastuzumab in combination with PEGylated interferon-α1b exerts synergistic antitumor activity through enhanced inhibition of HER2 downstream signaling and antibody-dependent cellular cytotoxicity.

Trastuzumab in combination with PEGylated interferon-α1b exerts synergistic antitumor activity through enhanced inhibition of HER2 downstream signaling and antibody-dependent cellular cytotoxicity.

Journal: American journal of cancer research

Published: October 08, 2021

Enabling Anionic Redox Stability of P2-Na5/6 Li1/4 Mn3/4 O2 by Mg Substitution.

Enabling Anionic Redox Stability of P2-Na5/6 Li1/4 Mn3/4 O2 by Mg Substitution.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: July 13, 2021

TSL-1502, a glucuronide prodrug of a poly (ADP-ribose) polymerase (PARP) inhibitor, exhibits potent anti-tumor activity in preclinical models.

TSL-1502, a glucuronide prodrug of a poly (ADP-ribose) polymerase (PARP) inhibitor, exhibits potent anti-tumor activity in preclinical models.

Journal: American journal of cancer research

Published: January 15, 2021

Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells.

Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells.

Journal: Thoracic cancer

Published: December 30, 2020

Mg-Pillared LiCoO2 : Towards Stable Cycling at 4.6 V.

Mg-Pillared LiCoO2 : Towards Stable Cycling at 4.6 V.

Journal: Angewandte Chemie (International ed. in English)

Published: October 23, 2020

YES1 amplification confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive cancer.

YES1 amplification confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive cancer.

Journal: British journal of cancer

Published: September 18, 2019

Showing 1-12 of 22

Last Updated: 09/26/2026